- Filed
- May 20, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · May 16, 2024 | 14.98M sh |
| Shares Diluted | Q2 2024 · Mar 31, 2024 | 14.98M sh |
| Shares Diluted | Q2 2024 · Mar 31, 2024 | 14.98M sh |
| Shares Diluted restated | Q2 2024 · Mar 31, 2023 | 732.92K sh |
| Shares Diluted restated | Q2 2024 · Mar 31, 2023 | 650.71K sh |
| Operating Cash Flow | Q2 2024 · Mar 31, 2024 | −$4.1M |
| Operating Cash Flow | Q2 2024 · Mar 31, 2023 | −$7.25M |
| Long Term Debt | Q2 2024 · Mar 31, 2024 | $586.47K |
| Long Term Debt | Q2 2024 · Sep 30, 2023 | $559.6K |
| Short Term Debt | Q2 2024 · Mar 31, 2024 | $46.1M |
| Short Term Debt | Q2 2024 · Sep 30, 2023 | $39.25M |
| Cash And Equivalents | Q2 2024 · Mar 31, 2024 | $632.98K |
| Cash And Equivalents | Q2 2024 · Sep 30, 2023 | $304.71K |
| Cash And Equivalents | Q2 2024 · Mar 31, 2023 | $3.47M |
| Cash And Equivalents | Q2 2024 · Sep 30, 2022 | $5.49M |
| Stockholders Equity | Q2 2024 · Mar 31, 2024 | −$56.18M |
| Stockholders Equity | Q2 2024 · Dec 31, 2023 | −$52.49M |
| Stockholders Equity | Q2 2024 · Sep 30, 2023 | −$48.42M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $25.72M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $21.37M |
| Stockholders Equity | Q2 2024 · Sep 30, 2022 | $21.77M |
| Current Liabilities | Q2 2024 · Mar 31, 2024 | $70.14M |
| Current Liabilities | Q2 2024 · Sep 30, 2023 | $62.97M |
| Total Liabilities | Q2 2024 · Mar 31, 2024 | $70.73M |
| Total Liabilities | Q2 2024 · Sep 30, 2023 | $63.52M |
| Current Assets | Q2 2024 · Mar 31, 2024 | $2.18M |
| Current Assets | Q2 2024 · Sep 30, 2023 | $2.28M |
| Total Assets | Q2 2024 · Mar 31, 2024 | $14.55M |
| Total Assets | Q2 2024 · Sep 30, 2023 | $15.1M |
| Eps Diluted | Q2 2024 · Mar 31, 2024 | −$0.34 |
| Eps Diluted | Q2 2024 · Mar 31, 2024 | −$0.59 |
| Eps Diluted restated | Q2 2024 · Mar 31, 2023 | −$7.60 |
| Eps Diluted restated | Q2 2024 · Mar 31, 2023 | −$22.54 |
| Eps Basic | Q2 2024 · Mar 31, 2024 | −$0.34 |
| Eps Basic | Q2 2024 · Mar 31, 2024 | −$0.59 |
| Eps Basic restated | Q2 2024 · Mar 31, 2023 | −$7.60 |
| Eps Basic restated | Q2 2024 · Mar 31, 2023 | −$22.54 |
| Sga Expense | Q2 2024 · Mar 31, 2024 | $2.13M |
| Sga Expense | Q2 2024 · Mar 31, 2024 | $4.79M |
| Sga Expense | Q2 2024 · Mar 31, 2023 | $3.4M |
| Sga Expense | Q2 2024 · Mar 31, 2023 | $6.78M |
| Net Income | Q2 2024 · Mar 31, 2024 | −$5.05M |
| Net Income | Q2 2024 · Mar 31, 2024 | −$8.87M |
| Net Income | Q2 2024 · Dec 31, 2023 | −$3.82M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$4.01M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$11.57M |
| Net Income | Q2 2024 · Dec 31, 2022 | −$7.56M |
| Operating Income | Q2 2024 · Mar 31, 2024 | −$1.92M |
| Operating Income | Q2 2024 · Mar 31, 2024 | −$4.46M |
| Operating Income | Q2 2024 · Mar 31, 2023 | −$964.45K |
| Operating Income | Q2 2024 · Mar 31, 2023 | −$3.12M |
| Gross Profit | Q2 2024 · Mar 31, 2024 | $1.65M |
| Gross Profit | Q2 2024 · Mar 31, 2024 | $3.7M |
| Gross Profit | Q2 2024 · Mar 31, 2023 | $4.99M |
| Gross Profit | Q2 2024 · Mar 31, 2023 | $10.88M |
| Cost Of Revenue | Q2 2024 · Mar 31, 2024 | $1.87M |
| Cost Of Revenue | Q2 2024 · Mar 31, 2024 | $4.11M |
| Cost Of Revenue | Q2 2024 · Mar 31, 2023 | $6.59M |
| Cost Of Revenue | Q2 2024 · Mar 31, 2023 | $15.11M |
| Revenue | Q2 2024 · Mar 31, 2024 | $3.52M |
| Revenue | Q2 2024 · Mar 31, 2024 | $7.81M |
| Revenue | Q2 2024 · Mar 31, 2023 | $11.58M |
| Revenue | Q2 2024 · Mar 31, 2023 | $25.99M |